As of now, ACTG is at $3.07 up 37%.. anyone have anything they want to share with the rest of us? :)

Today's Chart: http://ichart.yahoo.com/b?s=actg

http://finance.yahoo.com/q?s=ACTG&d=c&t=1d...1d&l=on&z=b&q=l

Correction..

Now it's trading at 3.60 up 62.16%

And the volume is through the roof. I wonder if it's just day traders having fun with momentum or if there's some news?

$3.80

Now it's +71.17%

no news....probably some newsletter writter spams them via investor char boards/email
(remember SLEU? ;-)

I don't play dogs with the fleas
;_)))

It's the number 1 Advanced stock on the Nasdaq for today.. (so far)

http://dynamic.nasdaq.com/asp/usmostactive...tactive=adv#adv

It's definitely a volitle stock.. It could easily fall like a rock. :)

ask fm

Interesting, who owns the stock other than Ron?

Could be..

Didn't he say something about getting into the Patent Litigation business? I think he may have posted that someplace in the last 2 months or so.

Maybe ACACIA has a big new shareholder... <shrug>

KC,
I read the news which came out yesterday and I beleive it's responcible for the rise...
NOTHING related to video streaming alleged patent
;-))

CombiMatrix to Present at the UBS Warburg Global Life Sciences Conference
Wednesday, September 3, 2003 7:30 AM
- BusinessWire

NEWPORT BEACH, Calif., Sep 3, 2003 (BUSINESS WIRE) -- Acacia Research Corporation (CBMX)(ACTG) announced today that Dr. Amit Kumar, President and Chief Executive Officer of CombiMatrix, will provide a company overview at the UBS Warburg Global Life Sciences Conference. A live transmission of the presentation will take place at 10:00 AM (PST) / 1:00 PM (EST) on Wednesday, September 24, 2003.

To access the live audio webcast, please go to UBS Warburg's site at www.ibb.ubs.com and click on the conference link. A replay of the presentation will be made available at the UBS Warburg site 3 hours after the actual presentation time and will be available until October 25, 2003.

ABOUT ACACIA RESEARCH CORPORATION

Acacia Research Corporation comprises two operating groups, Acacia Technologies Group and CombiMatrix Group.

The CombiMatrix group is developing a platform technology to rapidly produce customizable active biochips, which are semiconductor-based tools for use in identifying and determining the roles of genes, gene mutations and proteins. CombiMatrix's technology has a wide range of applications including DNA synthesis/diagnostics, drug discovery, and immunochemical detection. CombiMatrix's Express Track(SM) and siRNA Solutions™ are approaches to target diseases with siRNA compounds. The initial focus of Express Track(SM) are the following viral diseases:

Virus Collaborator

SARS NIAID/USAMRIID

HIV type 1 irsiCaixa-Dr. Bonaventura Clotet

HIV type 2 To Be Announced

West Nile virus To Be Announced

Human Papillomavirus type 16 To Be Announced

Human Herpes 8 (Kaposi's sarcoma) To Be Announced

Smallpox (Variola) To Be Announced

Influenza virus A To Be Announced

Influenza virus B To Be Announced

Hepatitis C To Be Announced

Could be..

Didn't he say something about getting into the Patent Litigation business? I think he may have posted that someplace in the last 2 months or so.

Maybe ACACIA has a big new shareholder... <shrug>[/b][/quote]
it might be in his best interest